4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001493152-22-019669
CIK 0001710340other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:36 PM ET
Size
5.5 KB
Accession
0001493152-22-019669
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Restricted Stock Units
2022-07-12+110,000→ 110,000 total→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:36 PM ET
- Size
- 5.5 KB